Biomaterials Explained

Biocompatibility: The Essential Requirement

Biocompatibility is the ability of a material to perform its intended function in the body without eliciting an unacceptable biological response. This is not a simple pass-fail property but a complex interaction between the material surface and the surrounding biological environment. When any material is implanted, proteins from blood and tissue fluid adsorb onto its surface within seconds. The identity, orientation, and conformation of these adsorbed proteins determine whether inflammatory cells attack the surface, whether bacteria can colonize it, and whether the surrounding tissue integrates with or encapsulates the implant.

The body foreign body response to an implant follows a predictable sequence. Within hours, acute inflammation brings neutrophils and monocytes to the implant surface. Over days, monocytes differentiate into macrophages that attempt to break down the material. If they cannot, macrophages fuse into multinucleated foreign body giant cells and the body walls off the implant with a fibrous capsule of collagen. For some applications like hip implants, this encapsulation is acceptable. For others like neural electrodes, the fibrous capsule degrades device performance and must be minimized through material and surface design.

Metallic Biomaterials

Titanium and its alloys are the gold standard for load-bearing orthopedic and dental implants. Titanium forms a stable, adherent oxide layer (TiO2) that is bioinert and promotes osseointegration, the direct bonding of living bone to the implant surface. Ti-6Al-4V is the most common alloy for hip stems, knee tibial trays, and dental implant screws, with a yield strength of about 900 megapascals and an elastic modulus of 110 gigapascals. However, this modulus is still much higher than cortical bone (15 to 25 gigapascals), causing stress shielding where the stiff implant carries the mechanical load that would normally stimulate bone, leading to bone resorption around the implant. Porous titanium structures produced by additive manufacturing can match the modulus of bone while maintaining adequate strength.

Stainless steel 316L is used for fracture fixation plates, screws, and temporary implants where eventual removal is planned. Its lower cost makes it preferred for trauma applications in developing countries. Cobalt-chromium alloys serve in articulating surfaces like the femoral head of hip replacements, where their exceptional hardness and wear resistance minimize particle generation. Nitinol (nickel-titanium shape memory alloy) is used for self-expanding cardiovascular stents that are compressed into a catheter, delivered to a blocked artery, and expand to their pre-set diameter at body temperature, holding the vessel open and restoring blood flow.

Ceramic and Polymer Biomaterials

Bioactive ceramics bond directly to bone through chemical reactions at the implant surface. Hydroxyapatite (Ca10(PO4)6(OH)2) has a composition similar to the mineral component of bone and is used as a coating on titanium implants to accelerate osseointegration. Bioactive glass (45S5 Bioglass), developed by Larry Hench in 1969, forms a hydroxycarbonate apatite layer when immersed in body fluid that bonds to both bone and soft tissue. Calcium phosphate cements can be injected as a paste that hardens in the bone defect, filling irregular cavities that pre-formed implants cannot match.

Alumina and zirconia ceramics are used for articulating bearing surfaces in hip replacements. Alumina-on-alumina bearings produce wear rates orders of magnitude lower than metal-on-polyethylene bearings, generating fewer wear particles and reducing the risk of osteolysis (bone destruction caused by inflammatory reactions to wear debris). Zirconia dental crowns combine strength exceeding 1,000 megapascals with tooth-like translucency and color, making them the leading material for aesthetic dental restorations.

Polymeric biomaterials range from permanent implants to fully resorbable devices. Ultra-high-molecular-weight polyethylene (UHMWPE) serves as the bearing surface in most hip and knee replacements, articulating against a metal or ceramic counterface. Cross-linking the polyethylene by irradiation dramatically reduces wear rates but decreases fracture resistance. Polymethyl methacrylate (PMMA) bone cement fills the gap between the implant and bone in cemented joint replacements, distributing loads and providing immediate fixation. Silicone elastomers are used in breast implants, finger joint replacements, and catheters.

Biodegradable Materials and Tissue Engineering

Biodegradable biomaterials dissolve harmlessly in the body over time, eliminating the need for surgical removal and allowing natural tissue to replace the implant. Polylactic acid (PLA), polyglycolic acid (PGA), and their copolymer PLGA degrade by hydrolysis into lactic and glycolic acid, naturally occurring metabolites that the body processes through normal biochemical pathways. Degradation rates can be tuned from weeks to years by adjusting the copolymer ratio, molecular weight, and crystallinity. These polymers serve as absorbable sutures, fracture fixation pins and screws, and drug delivery microspheres.

Biodegradable metals represent a newer class of resorbable implants. Magnesium alloys dissolve in the body through corrosion, producing magnesium ions that are naturally present in the body (the fourth most abundant cation in humans). Magnesium screws for bone fracture fixation provide mechanical support during healing and then dissolve, avoiding the second surgery required to remove permanent metal hardware. The challenge is controlling the corrosion rate so the implant maintains adequate strength throughout the healing period.

Tissue engineering combines biodegradable scaffolds with living cells and growth factors to regenerate damaged tissue. The scaffold provides a three-dimensional template that guides cell attachment, proliferation, and differentiation into functional tissue. As the cells produce their own extracellular matrix, the scaffold degrades and is replaced by new tissue. Decellularized tissues, where the cells are removed from a donor organ or tissue using detergent solutions while preserving the extracellular matrix architecture, provide natural scaffolds with the correct three-dimensional structure, mechanical properties, and biochemical signals to guide tissue regeneration.

Surface Modification and Biointerface Engineering

The biological response to an implant is largely determined by its surface rather than its bulk properties, making surface modification a powerful tool for improving biomaterial performance. Plasma treatment exposes polymer surfaces to ionized gas that introduces reactive chemical groups (hydroxyl, carboxyl, or amine) without altering bulk properties, improving cell attachment and wettability. Hydroxyapatite coatings applied to titanium implants by plasma spraying accelerate bone bonding from months to weeks, a technology now standard for cementless hip and knee replacement components.

Anti-fouling surface coatings prevent protein adsorption and bacterial colonization that lead to implant infection and failure. Polyethylene glycol (PEG) brushes grafted to implant surfaces create a hydrated layer that resists protein adsorption through steric and osmotic repulsion. Zwitterionic polymer coatings, with equal numbers of positive and negative charges, are even more effective at resisting biological fouling while maintaining zero net charge. Antimicrobial surfaces incorporating silver nanoparticles, copper ions, or covalently bonded antimicrobial peptides actively kill bacteria on contact, addressing the growing threat of antibiotic-resistant implant infections that affect roughly 2 percent of orthopedic implants and cost billions of dollars annually to treat.

Micro and nanostructured surfaces influence cell behavior through topographic cues. Titanium surfaces with controlled nanotube arrays (produced by anodization) promote osteoblast differentiation and bone formation. Micropatterned surfaces that mimic the extracellular matrix guide stem cell differentiation toward specific tissue types depending on pattern geometry, stiffness, and chemical functionality. These surface engineering approaches are transforming biomaterial design from passive material selection toward active control of the biological response at the cell-material interface.

Drug Delivery Systems

Biomaterial-based drug delivery systems control the rate, duration, and location of drug release to maximize therapeutic effect while minimizing side effects. Drug-eluting stents incorporate anti-proliferative drugs (such as everolimus or zotarolimus) in a polymer coating that releases the drug over weeks to months, preventing the smooth muscle cell overgrowth that can re-block a treated artery. Polymer microspheres of PLGA loaded with peptide drugs like leuprolide provide steady release for one to six months from a single injection, replacing daily injections for prostate cancer treatment and other hormone therapies.

Targeted delivery using nanoparticles aims to concentrate drugs at disease sites while sparing healthy tissue. Antibody-conjugated nanoparticles recognize specific receptors on cancer cells, pH-responsive polymers release their drug payload in the acidic environment inside tumors, and magnetic nanoparticles can be guided to specific locations using external magnetic fields. These approaches are gradually entering clinical use, with several nanoparticle drug formulations (including liposomal doxorubicin and albumin-bound paclitaxel) now approved and in routine clinical practice.